Innovative Therapy, Monoclonal Antibodies and Beyond (original) (raw)
Related papers
The importance of predictive biomarkers in oncology drug development
Expert review of molecular diagnostics, 2016
Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use
Clinical Cancer Research, 2012
Translational Oncogenomics, 2015
Proof of Concept to Clinical Confirmation: Evolving Clinical Trial Designs for Targeted Agents
ISRN Oncology, 2012
A paradigm shift in biomarker guided oncology drug development
Annals of Translational Medicine
Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
Monoclonal Antibodies (mAbs) Approved for Cancer Treatment in the 2020s
Trends in Medical Sciences, 2021
Therapeutic Monoclonal Antibodies: Past, Present, and Future
John Wiley & Sons, Inc. eBooks, 2009
Therapeutic Monoclonal Antibodies: Future Prospectives
Journal of Cancer Immunology, 2021
Effective Incorporation of Biomarkers into Phase II Trials
Clinical Cancer Research, 2009
An appraisal of drug development timelines in the Era of precision oncology
Oncotarget, 2014
Clinical Cancer Research, 2012
Making Biomarkers Relevant to Healthcare Innovation and Precision Medicine
Processes
Successes Achieved and Challenges Ahead in Translating Biomarkers into Clinical Applications
The AAPS Journal, 2010
Trial Watch: Monoclonal antibodies in cancer therapy
OncoImmunology, 2012
When biomarkers define a drug indication
Expert Review of Molecular Diagnostics
Monoclonal antibodies: Innovations in diagnosis and therapy
1996
Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer
BMC Cancer, 2016
Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities
Journal of Cellular Biochemistry
British journal of cancer, 2018
Journal of clinical pharmacology, 2016
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications
Jérôme Galon, Alexander Eggermont
OncoImmunology, 2015
Developing therapeutic monoclonal antibodies at pandemic pace
Nature Biotechnology, 2020
Frontiers of monoclonal antibodies: Applications in medical practices
Reinventing diagnostics for personalized therapy in oncology
Cancers, 2010
100% Human Monoclonal Antibodies in Oncology: Hype or Breakthrough?
Current Topics in Medicinal Chemistry, 2012
Journal of Clinical Oncology, 2014
Developments in therapy with monoclonal antibodies and related proteins
Clinical medicine (London, England), 2017
Targeting targeted agents: open issues for clinical trial design
Journal of Experimental & Clinical Cancer Research, 2009
The role of biomarkers in the development of novel cancer therapies
Drug Metabolism and Drug Interactions, 2012